Bristol-Myers (BMY) to terminate Avagacestat clinical developmen
Go back to Bristol-Myers (BMY) to terminate Avagacestat clinical developmen| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.42 +1.95 (2.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.47 | 52 Week High | $77.12 | |||
| Open | $65.79 | 52 Week Low | $49.03 | |||
| Day High | $67.55 | P/E | 43.78 | |||
| Day Low | $65.13 | EPS | $1.54 | |||
| Volume | 4,608,036 | |||||
